DJIA 16,614.81 215.14 1.31%
NASDAQ 4,419.48 103.40 2.40%
S&P 500 1,941.28 37.27 1.96%
market minute promo

ImmunoGen (NASDAQ: IMGN)

8.84 -0.62 (-6.55%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

IMGN $8.84 -6.55%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $9.56
Previous Close $9.46
Daily Range $8.57 - $9.71
52-Week Range $7.70 - $18.19
Market Cap $759.4M
P/E Ratio -11.40
Dividend (Yield) $0.00 (0.0%)
Volume 1,622,590
Average Daily Volume 1,280,219
Current FY EPS -$0.70





ImmunoGen (IMGN) Description

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs. Website:

News & Commentary Rss Feed

3 Value Stocks Near 52-Week Lows Worth Buying

These value stocks may be hitting a new 52-week low, but they may not be there for long!

ImmunoGen (IMGN) in Focus: Stock Rallies 14% - Tale of the Tape

ImmunoGen (IMGN) in Focus: Stock Rallies 14% - Tale of the Tape

Immunogen (IMGN) Highlighted As Today's Perilous Reversal Stock

Trade-Ideas: Immunogen (IMGN) Is Today's Strong On High Relative Volume Stock

Today's Weak On High Volume Stock: Immunogen (IMGN)

First Week of IMGN November 22nd Options Trading

Breast Cancer Occurs Most Often in These 5 States

Breast cancer was diagnosed in more than 220,000 women in 2011. Find out in which five states a breast cancer diagnosis is the most common, as well as what current and developing therapies are being used to treat this terrible disease.

Why ImmunoGen, Inc. Stock Crashed 22% in 2014

While the S&P Biotech index soars, ImmunoGen shareholders are getting left in the dust. Find out what's been holding shares back in 2014, and whether or not ImmunoGen will rebound from its current price.

SEC Slaps Biotech Hedge Fund for Short-Selling Violations

ETF Rebalance Could Make 5 Biotech Stocks Shoot Higher

See More IMGN News...

IMGN's Top Competitors

IMGN $8.84 (-6.55%)
Current stock: IMGN
AMGN $144.09 (4.79%)
Current stock: AMGN
GILD $106.67 (4.36%)
Current stock: GILD
BIIB $326.77 (4.93%)
Current stock: BIIB